Order results by:
| Issue | Title | |
| Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз | Ways to improve adherence to long-term injection therapy in multiple sclerosis using the example of pegylated interferon-β1a (sampeginterferon β-1a) | Abstract similar documents |
| A. N. Boyko | ||
| "... Patient adherence to therapy with multiple sclerosis disease-modifying treatments (MS DMTs ..." | ||
| Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | The central vein sign in the differential diagnosis of multiple sclerosis | Abstract similar documents |
| S. E. Belov, A. N. Boyko | ||
| "... The current diagnosis of multiple sclerosis (MS) is based on confirmation of the disseminated ..." | ||
| Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | Informative value of neuropsychological tests for multiple sclerosis | Abstract similar documents |
| A. R. Kabaeva, A. N. Boyko | ||
| "... Cognitive impairment (CI) occurs in 43–70% of patients with multiple sclerosis (MS) at both early ..." | ||
| Vol 16 (2024): (Suppl. 2) | Optimization of therapy in secondary progressive multiple sclerosis | Abstract similar documents |
| A. N. Boyko, S. K. Zyryanov, Ya. V. Vlasov | ||
| "... The article provides an analysis of modern methods of treatment of secondary progressive multiple ..." | ||
| Vol 15, No 6 (2023) | «Gut-brain» axis and multiple sclerosis | Abstract similar documents |
| M. A. Omarova, A. N. Boyko | ||
| "... An increase in the incidence of multiple sclerosis (MS) has been reported over the last decade ..." | ||
| Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | Rehabilitation of patients with multiple sclerosis in terms of evidence-based medicine: techniques for digitizing the results | Abstract similar documents |
| S. A. Ryabov, A. N. Boyko | ||
| "... the effectiveness of rehabilitation in patients with multiple sclerosis (MS). It is necessary to investigate ..." | ||
| Vol 15 (2023): (Suppl. 1) | Distinctive parameters of gait in patients with multiple sclerosis, depending on the profile of its dysfunction | Abstract similar documents |
| S. A. Ryabov, A. N. Boyko | ||
| "... Objective: to identify characteristic gait parameters by video analysis in patients with multiple ..." | ||
| Vol 15 (2023): (Suppl. 1) | Prolonged observation after the use of cladribine in multiple sclerosis: efficacy and safety | Abstract similar documents |
| A. D. Kukushkina, A. N. Boyko | ||
| "... Multiple sclerosis (MS) is a chronic disease whose pathogenesis is based on autoimmune ..." | ||
| Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | Experience with cladribine tablets for highly active multiple sclerosis in everyday clinical practice | Abstract similar documents |
| S. V. Petrov, O. V. Boyko, A. N. Boyko | ||
| "... give their own experience of its use in the Moscow Multiple Sclerosis Center. Objective: to assess ..." | ||
| Vol 15 (2023): (Suppl. 1) | Prospects for the use of curcumin as an additional treatment for multiple sclerosis | Abstract similar documents |
| V. S. Rogovskii, A. D. Kukushkina, A. N. Boyko | ||
| "... Multiple sclerosis (MS) is a chronic demyelinating autoimmune disease. MS therapy does not always ..." | ||
| Vol 11, No 4 (2019) | Current requirements for studies of drugs for the pathogenetic treatment of multiple sclerosis | Abstract similar documents |
| A. N. Boyko, N. N. Spirin, Ya. V. Vlasov, M. N. Zakharova | ||
| "... More than 10 multiple sclerosis-modifying drugs (MSMDs) are widely used now. Novel MSMDs should ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Comparison of medical and social characteristics and quality of life of patients with primary- and secondary-progressive multiple sclerosis | Abstract similar documents |
| Ya. V. Vlasov, N. G. Polyarnaya, A. N. Boyko | ||
| "... Management of patients with secondary progressive multiple sclerosis (SPMS) remains one ..." | ||
| Vol 14, No 1 (2022) | Experience with cladribine tablets for highly active multiple sclerosis in real clinical practice | Abstract similar documents |
| S. V. Petrov, O. V. Boyko, A. N. Boyko | ||
| "... reconstitution of highly active multiple sclerosis (HAMS) in general clinical practice. Patients and methods. 34 ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Mechanisms of brain protection against autoimmune inflammation | Abstract similar documents |
| A. I. Volkov, M. V. Melnikov, A. N. Boyko | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Art therapy possibilities in the complex treatment of patients with multiple sclerosis | Abstract similar documents |
| M. E. Guseva, O. V. Matvievskaya, A. N. Boyko | ||
| "... -progressive multiple sclerosis (MS). Patients and methods. A group of 42 patients (5 men and 37 women, mean ..." | ||
| Vol 10, No 1 (2018) | New drugs for anti-B-cell therapy of multiple sclerosis | Abstract similar documents |
| A. N. Boyko, N. Yu. Lashch, M. E. Guseva | ||
| "... for multiple sclerosis (MS) and the results of clinical trials of ocrelizumab, the first drug of this group ..." | ||
| Vol 15 (2023): (Suppl. 1) | The evolution of interferon therapy in multiple sclerosis | Abstract similar documents |
| O. V. Boyko, N. F. Smirnova, A. N. Boyko | ||
| "... The article reviews the evolution of interferon-β (IFN-β) in the treatment of multiple sclerosis ..." | ||
| Vol 16 (2024): (Suppl. 2) | Results of tele-rehabilitation in patients with multiple sclerosis during 2020–2021 COVID-19 pandemic | Abstract similar documents |
| S. A. Sivertseva, K. S. Anfilofeva, A. V. Zotova, V. D. Chukreev, A. Yu. Belkina, L. I. Volkova, M. E. Guseva, A. N. Boyko | ||
| "... Multiple sclerosis (MS) is a chronic autoimmune disease of the nervous system of a predominantly ..." | ||
| Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз | Free circulating miRNA as a potential diagnostic marker in multiple sclerosis (review) | Abstract similar documents |
| M. A. Omarova, M. S. Kozin, A. N. Boyko | ||
| "... in the concentration of miRNAs in the CSF of patients with multiple sclerosis (MS) and patients with other neurological ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Attitude to reproduced disease modifying therapies in patients with relapsing-remitting multiple sclerosis: results of a medical and sociological study | Abstract similar documents |
| Ya. V. Vlasov, M. V. Churakov, E. V. Sineok, A. N. Boyko | ||
| "... The problem of an adequate choice of a treatment method in multiple sclerosis (MS) remains one ..." | ||
| Vol 15, No 4 (2023) | Paramagnetic rim sign in multiple sclerosis | Abstract similar documents |
| D. V. Kapkanets, S. E. Belov, M. B. Dolgushin, A. N. Boyko | ||
| "... To date, there is no accepted highly specific pattern for the detection of multiple sclerosis ..." | ||
| Vol 15 (2023): (Suppl. 1) | MicroRNAs as biomarkers of multiple sclerosis progression | Abstract similar documents |
| N. M. Baulina, I. S. Kiselev, O. G. Kulakova, E. V. Popova, O. O. Favorova, A. N. Boyko | ||
| "... Multiple sclerosis (MS) is an autoimmune inflammatory neurodegenerative disease of the central ..." | ||
| Vol 16 (2024): (Suppl. 2) | Curcumin as an add-on therapy for multiple sclerosis in patients receiving interferon-beta therapy | Abstract similar documents |
| A. D. Kukushkina, V. S. Rogovskii, E. V. Ponevezhskaya, E. V. Lysogorskaia, A. N. Boyko | ||
| "... Search for agents for the add-on therapy of multiple sclerosis (MS) that can enhance the effect ..." | ||
| Vol 17, No 1 (2025) | Contribution of genomic variation to the severity of multiple sclerosis | Abstract similar documents |
| O. G. Kulakova, N. A. Matveeva, I. S. Kiselev, A. N. Boyko, O. O. Favorova | ||
| "... Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system of polygenic ..." | ||
| Vol 13, No 1 (2021) | New possibilities of siponimod therapy in patients with secondary progressive multiple sclerosis | Abstract similar documents |
| D. S. Kasatkin, N. V. Khachanova, V. M. Alifirova, A. N. Boyko, K. Z. Bakhtiyarova, Ya. V. Vlasov, M. V. Davydovskaya, E. P. Evdoshenko, S. A. Sivertseva | ||
| "... The process of neurodegeneration in multiple sclerosis (MS) remains an urgent problem of modern ..." | ||
| Vol 11, No 3 (2019) | Clinical recommendations for the use of ocrelizumab in patients with multiple sclerosis | Abstract similar documents |
| A. N. Boyko, M. V. Davydovskaya, N. V. Khachanova, M. N. Zakharova, N. N. Spirin, E. V. Popova, V. M. Alifirova, Ya. V. Vlasov, S. A. Sivertseva, F. A. Khabirov, M. V. Shumilina, E. P. Evdoshenko | ||
| "... multiple sclerosis and primary progressive multiple sclerosis in the use of ocrelizumab. ..." | ||
| Vol 14, No 2 (2022) | Changes in expression of miRNAs from the DLK1-DIO3 locus are characteristic of relapsing-remitting multiple sclerosis regardless of the disease activity | Abstract similar documents |
| N. M. Baulina, A. R. Kabaeva, A. N. Boyko, O. O. Favorova | ||
| "... The role of miRNAs – small, regulatory, noncoding RNAs – in the multiple sclerosis (MS ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Influence of von Willebrand factor on common pathophysiological mechanisms of cerebrovascular diseases and multiple sclerosis | Abstract similar documents |
| I. A. Koltsov, M. Yu. Martynov, A. N. Yasamanova, I. A. Shchukin, M. S. Fidler, A. N. Boyko | ||
| "... to the development/progression of many diseases, including cerebrovascular disease and multiple sclerosis. Von ..." | ||
| Vol 11, No 1 (2019) | Experience with anti-B-cell therapy in the pathogenetic treatment of multiple sclerosis | Abstract PDF (Eng) similar documents |
| O. V. Boyko, S. V. Petrov, N. Yu. Lashch, M. R. Guseva, A. N. Boyko | ||
| "... One of the promising areas in the pathogenetic treatment of multiple sclerosis (MS) is anti-B-cell ..." | ||
| Vol 11, No 3 (2019) | Mitochondrial genome and risk of multiple sclerosis | Abstract similar documents |
| A. N. Boyko, M. S. Kozin, G. Zh. Osmak, O. G. Kulakova, O. O. Favorova | ||
| "... risk of multiple sclerosis (MS). Objective: to analyze the frequency of mtDNA variants in patients ..." | ||
| Vol 17, No 3 (2025) | Curcumin as add-on therapy in patients with multiple sclerosis showing a suboptimal response to first-line disease-modifying therapies: clinical outcomes and in vitro data | Abstract similar documents |
| A. D. Kukushkina, V. S. Rogovskii, E. V. Ponevezhskaia, E. V. Lysogorskaia, A. N. Boyko | ||
| "... In recent decades, pathogenetic therapy of multiple sclerosis (MS) has advanced significantly due ..." | ||
| Vol 17, No 3 (2025) | Switching from ocrelizumab to ofatumumab: key potential reasons based on real-world clinical practice | Abstract similar documents |
| A. N. Boyko, T. O. Simaniv, T. A. Prokopyeva, S. V. Petrov, M. V. Melnikov | ||
| "... important role in the treatment of active forms of multiple sclerosis (MS). Among the most well-studied ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Microbiota markers level in the cerebrospinal fluid of patients with multiple sclerosis and radiologically isolated syndrome | Abstract similar documents |
| A. N. Boyko, M. V. Melnikov, O. V. Boyko, A. R. Kabaeva, M. A. Omarova, O. G. Zhilenkova, A. M. Zatevalov, V. S. Rogovskii | ||
| "... According to numerous studies, gut microbiota plays a significant role in multiple sclerosis (MS ..." | ||
| Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | Polymorphic variants in the PVT1 locus affect multiple sclerosis severity | Abstract PDF (Eng) similar documents |
| I. S. Kiselev, M. S. Kozin, N. M. Baulina, G. V. Pavlova, A. N. Boyko, O. G. Kulakova, O. O. Favorova | ||
| "... Multiple sclerosis (MS) is a chronic autoimmune disease, in the pathogenesis of which ..." | ||
| Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | The combined effect of nuclear and mitochondrial genomes on the risk of developing multiple sclerosis | Abstract PDF (Eng) similar documents |
| M. S. Kozin, I. S. Kiselev, A. N. Boyko, O. G. Kulakova, O. O. Favorova | ||
| "... Multiple sclerosis (MS) is a severe chronic CNS disease characterized by autoimmune inflammation ..." | ||
| Vol 16 (2024): (Suppl. 2) | Global transcriptome profiling of blood mononuclear cells from individuals with radiologically isolated syndrome reveals abnormalities characteristic of the rapid manifestation of multiple sclerosis symptoms | Abstract similar documents |
| M. S. Kozin, A. R. Kabaeva, M. A. Omarova, A. N. Boyko, O. O. Favorova, O. G. Kulakova | ||
| "... of a group of patients with radiologically isolated syndrome (RIS) who developed symptoms of multiple ..." | ||
| Vol 12, No 3 (2020) | Recommendations for the use of cladribine tablets for the pathogenetic treatment of patients with highly active multiple sclerosis | Abstract similar documents |
| K. Z. Bakhtiyarova, A. N. Boyko, Ya. V. Vlasov, Z. A. Goncharova, M. V. Davydovskaya, M. N. Zakharova, N. A. Malkova, A. I. Nilov, S. A. Sivertseva, N. N. Spirin, N. A. Totolyan, F. A. Khabirov, M. V. Shumilina | ||
| "... Currently, special attention is paid to timely treatment for active forms of multiple sclerosis ..." | ||
| Vol 13, No 2 (2021) | COVID-19 vaccination guidelines for patients with multiple sclerosis | Abstract similar documents |
| N. V. Khachanova, N. A. Totolyan, Ya. V. Vlasov, S. A. Sivertseva, M. V. Davydovskaya, E. P. Evdoshenko, A. P. Prodeus, M. N. Zakharova, N. N. Spirin, A. N. Boyko | ||
| "... with multiple sclerosis (MS) is presented. The authors of the consensus, based on an analysis of a large number ..." | ||
| Vol 11, No 4 (2019) | Recommendations from the Expert Meeting «Secondary progressive multiple sclerosis: unresolved issues and prospects» | Abstract similar documents |
| N. V. Khachanova, A. N. Boyko, K. Z. Bakhtiyarova, Ya. V. Vlasov, E. P. Evdoshenko, S. A. Sivertseva, T. E. Schmidt, M. V. Shumilina | ||
| "... progressive multiple sclerosis (MS) (SPMS), clinical trials, and promising treatments for the progressive MS ..." | ||
| Vol 12, No 5 (2020) | Recommendations for switching patients with highly active multiple sclerosis from other disease modifying drugs for multiple sclerosis to cladribine tablets | Abstract similar documents |
| N. A. Totolyan, V. M. Alifirova, K. Z. Bakhtiyarova, A. N. Boyko, Ya. V. Vlasov, Z. A. Goncharova, M. N. Zakharova, D. S. Kasatkin, S. V. Kotov, A. I. Nilov, S. A. Sivertseva, A. A. Sokolova, N. N. Spirin, F. A. Khabirov, D. Paradnika | ||
| "... The need for optimal treatment of the active forms of multiple sclerosis (MS), especially highly ..." | ||
| Vol 15, No 6 (2023) | Russian-Belarusian Expert Council “New opportunities in the treatment of patients with multiple sclerosis” (October 1, 2023). Main conclusions of the first meeting | Abstract similar documents |
| A. N. Boyko, V. V. Vashchilin, O. V. Boyko, A. G. Bunyak, D. S. Kasatkin, D. S. Korobko, S. I. Kulikova, N. V. Mazgo, N. V. Makovskaya, S. A. Sivertseva, I. V. Smagina, T. N. Chernukha | ||
| "... of patients with multiple sclerosis” on the organization of medical care, diagnosis and treatment of multiple ..." | ||
| Vol 13, No 3 (2021) | Results of Expert Council meeting on modern principles of treatment optimization in patients with relapsing-remitting multiple sclerosis using anti-CD20 monoclonal antibody | Abstract similar documents |
| A. N. Boyko, N. V. Khachanova, D. S. Korobko, D. S. Kasatkin, Ya. V. Vlasov, E. P. Evdoshenko, E. V. Popova, K. Z. Bakhtiyarova, S. A. Sivertseva | ||
| "... The article presents the results of the discussion of the use of anti-B-cell therapy in multiple ..." | ||
| Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз | Reduced expression of the tumor necrosis factor gene in blood mononuclear cells in radiologically isolated syndrome – validation of transcriptome analysis results | Abstract similar documents |
| M. S. Kozin, N. M. Baulina, I. S. Kiselev, A. R. Kabaeva, A. N. Boyko, O. O. Favorova, O. G. Kulakova | ||
| "... (MRI) reveals lesions of the white matter of the brain and/or spinal cord characteristic of multiple ..." | ||
| Vol 16 (2024): (Suppl. 2) | Experience with the use of cladribine tablets in real-life clinical practice: independent analysis of data from 12 Russian clinical centres | Abstract similar documents |
| A. N. Boyko, V. M. Alifirova, D. V. Pashkovskaya, E. I. Kuchina, S. A. Sivertseva, E. L. Turova, Z. A. Goncharova, O. Yu. Rudenko, Yu. Yu. Pogrebnova, F. A. Khabirov, T. I. Khaibullin, N. N. Babicheva, N. L. Khoroshilova, O. V. Dzundza, O. A. Soldatova, A. N. Belova, G. Е. Sheiko, A. Е. Makarova, N. G. Glavinskaya | ||
| "... Multiple sclerosis (MS) is an autoimmune-inflammatory and neurodegenerative disease of the central ..." | ||
| 1 - 44 of 44 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
